Short-term results of catheter-directed intrathrombus thrombolysis versus anticoagulation in acute proximal deep vein thrombosis

Chiu Yang Lee, Shiau Ting Lai, Chun Che Shih, Tao Cheng Wu

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Background: Deep vein thrombosis (DVT) is a potentially progressive disease with complex clinical sequelae. The clinical practice guidelines of the American College of Chest Physicians (ACCP) recommend various treatments for all patients with objectively proven DVT. This study retrospectively compares enoxaparin with CDT on treatment efficacy and safety and the evolution of acute proximal DVT in the lower limbs. Methods: This study comprised 53 patients with acute proximal DVT, who received either CDT followed by intravenous unfractionated heparin (UFH) or adjusted subcutaneous low-molecular-weight heparin (LMWH) (enoxaparin) for 7-14 days. Warfarin was administered to all patients for at least 6 months. The study endpoints included the evolution of DVT and treatment efficacy and safety, which were assessed with frequent duplex ultrasounds, plethysmography, and venography. The mean duration of the follow-up was 15.2 months. Results: In the CDT group, patency of the iliofemoral vein segment was observed in 42.3% of the patients after 1 week (p < 0.001) and in 69.2% after 6 months. In the control group, patency was present in 15.4% of the patients after 3 months and in 38.5% after 6 months (p = 0.05). Femoral venous obstruction was found in 30.8% of CDT patients and in 61.5% of the control group (p = 0.05). Furthermore, femoral venous insufficiency was present in 46.2% of the CDT group and 53.9% of the control group after 6 months (p = 0.587). After 12 months, post-thrombotic syndrome (PTS) was found in 19.2% of the CDT patients compared to 50% of the LMWH group (p = 0.04). Conclusion: Duplex ultrasound analysis of thrombus progression is useful for assessing the treatment of a patient with acute proximal DVT. In this study, patients undergoing CDT experienced higher thrombus resolution and early recanalization of their veins, which may preserve venous function and further prevent development of post-thrombotic syndrome.

Original languageEnglish
Pages (from-to)265-270
Number of pages6
JournalJournal of the Chinese Medical Association
Volume76
Issue number5
DOIs
Publication statusPublished - May 1 2013
Externally publishedYes

Fingerprint

Venous Thrombosis
Catheters
Enoxaparin
Low Molecular Weight Heparin
Thigh
Control Groups
Veins
Thrombosis
Safety
Venous Insufficiency
Plethysmography
Phlebography
Warfarin
Practice Guidelines
Heparin
Lower Extremity
Therapeutics

Keywords

  • Catheter-directed intrathrombus thrombolysis
  • Deep vein thrombosis
  • Low-molecular-weight heparin
  • Post-thrombotic syndrome
  • Unfractionated heparin

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Short-term results of catheter-directed intrathrombus thrombolysis versus anticoagulation in acute proximal deep vein thrombosis. / Lee, Chiu Yang; Lai, Shiau Ting; Shih, Chun Che; Wu, Tao Cheng.

In: Journal of the Chinese Medical Association, Vol. 76, No. 5, 01.05.2013, p. 265-270.

Research output: Contribution to journalArticle

@article{ece3645bb3874fc293b3ccc3a863713d,
title = "Short-term results of catheter-directed intrathrombus thrombolysis versus anticoagulation in acute proximal deep vein thrombosis",
abstract = "Background: Deep vein thrombosis (DVT) is a potentially progressive disease with complex clinical sequelae. The clinical practice guidelines of the American College of Chest Physicians (ACCP) recommend various treatments for all patients with objectively proven DVT. This study retrospectively compares enoxaparin with CDT on treatment efficacy and safety and the evolution of acute proximal DVT in the lower limbs. Methods: This study comprised 53 patients with acute proximal DVT, who received either CDT followed by intravenous unfractionated heparin (UFH) or adjusted subcutaneous low-molecular-weight heparin (LMWH) (enoxaparin) for 7-14 days. Warfarin was administered to all patients for at least 6 months. The study endpoints included the evolution of DVT and treatment efficacy and safety, which were assessed with frequent duplex ultrasounds, plethysmography, and venography. The mean duration of the follow-up was 15.2 months. Results: In the CDT group, patency of the iliofemoral vein segment was observed in 42.3{\%} of the patients after 1 week (p < 0.001) and in 69.2{\%} after 6 months. In the control group, patency was present in 15.4{\%} of the patients after 3 months and in 38.5{\%} after 6 months (p = 0.05). Femoral venous obstruction was found in 30.8{\%} of CDT patients and in 61.5{\%} of the control group (p = 0.05). Furthermore, femoral venous insufficiency was present in 46.2{\%} of the CDT group and 53.9{\%} of the control group after 6 months (p = 0.587). After 12 months, post-thrombotic syndrome (PTS) was found in 19.2{\%} of the CDT patients compared to 50{\%} of the LMWH group (p = 0.04). Conclusion: Duplex ultrasound analysis of thrombus progression is useful for assessing the treatment of a patient with acute proximal DVT. In this study, patients undergoing CDT experienced higher thrombus resolution and early recanalization of their veins, which may preserve venous function and further prevent development of post-thrombotic syndrome.",
keywords = "Catheter-directed intrathrombus thrombolysis, Deep vein thrombosis, Low-molecular-weight heparin, Post-thrombotic syndrome, Unfractionated heparin",
author = "Lee, {Chiu Yang} and Lai, {Shiau Ting} and Shih, {Chun Che} and Wu, {Tao Cheng}",
year = "2013",
month = "5",
day = "1",
doi = "10.1016/j.jcma.2013.01.006",
language = "English",
volume = "76",
pages = "265--270",
journal = "Journal of the Chinese Medical Association",
issn = "1726-4901",
publisher = "Elsevier Taiwan LLC",
number = "5",

}

TY - JOUR

T1 - Short-term results of catheter-directed intrathrombus thrombolysis versus anticoagulation in acute proximal deep vein thrombosis

AU - Lee, Chiu Yang

AU - Lai, Shiau Ting

AU - Shih, Chun Che

AU - Wu, Tao Cheng

PY - 2013/5/1

Y1 - 2013/5/1

N2 - Background: Deep vein thrombosis (DVT) is a potentially progressive disease with complex clinical sequelae. The clinical practice guidelines of the American College of Chest Physicians (ACCP) recommend various treatments for all patients with objectively proven DVT. This study retrospectively compares enoxaparin with CDT on treatment efficacy and safety and the evolution of acute proximal DVT in the lower limbs. Methods: This study comprised 53 patients with acute proximal DVT, who received either CDT followed by intravenous unfractionated heparin (UFH) or adjusted subcutaneous low-molecular-weight heparin (LMWH) (enoxaparin) for 7-14 days. Warfarin was administered to all patients for at least 6 months. The study endpoints included the evolution of DVT and treatment efficacy and safety, which were assessed with frequent duplex ultrasounds, plethysmography, and venography. The mean duration of the follow-up was 15.2 months. Results: In the CDT group, patency of the iliofemoral vein segment was observed in 42.3% of the patients after 1 week (p < 0.001) and in 69.2% after 6 months. In the control group, patency was present in 15.4% of the patients after 3 months and in 38.5% after 6 months (p = 0.05). Femoral venous obstruction was found in 30.8% of CDT patients and in 61.5% of the control group (p = 0.05). Furthermore, femoral venous insufficiency was present in 46.2% of the CDT group and 53.9% of the control group after 6 months (p = 0.587). After 12 months, post-thrombotic syndrome (PTS) was found in 19.2% of the CDT patients compared to 50% of the LMWH group (p = 0.04). Conclusion: Duplex ultrasound analysis of thrombus progression is useful for assessing the treatment of a patient with acute proximal DVT. In this study, patients undergoing CDT experienced higher thrombus resolution and early recanalization of their veins, which may preserve venous function and further prevent development of post-thrombotic syndrome.

AB - Background: Deep vein thrombosis (DVT) is a potentially progressive disease with complex clinical sequelae. The clinical practice guidelines of the American College of Chest Physicians (ACCP) recommend various treatments for all patients with objectively proven DVT. This study retrospectively compares enoxaparin with CDT on treatment efficacy and safety and the evolution of acute proximal DVT in the lower limbs. Methods: This study comprised 53 patients with acute proximal DVT, who received either CDT followed by intravenous unfractionated heparin (UFH) or adjusted subcutaneous low-molecular-weight heparin (LMWH) (enoxaparin) for 7-14 days. Warfarin was administered to all patients for at least 6 months. The study endpoints included the evolution of DVT and treatment efficacy and safety, which were assessed with frequent duplex ultrasounds, plethysmography, and venography. The mean duration of the follow-up was 15.2 months. Results: In the CDT group, patency of the iliofemoral vein segment was observed in 42.3% of the patients after 1 week (p < 0.001) and in 69.2% after 6 months. In the control group, patency was present in 15.4% of the patients after 3 months and in 38.5% after 6 months (p = 0.05). Femoral venous obstruction was found in 30.8% of CDT patients and in 61.5% of the control group (p = 0.05). Furthermore, femoral venous insufficiency was present in 46.2% of the CDT group and 53.9% of the control group after 6 months (p = 0.587). After 12 months, post-thrombotic syndrome (PTS) was found in 19.2% of the CDT patients compared to 50% of the LMWH group (p = 0.04). Conclusion: Duplex ultrasound analysis of thrombus progression is useful for assessing the treatment of a patient with acute proximal DVT. In this study, patients undergoing CDT experienced higher thrombus resolution and early recanalization of their veins, which may preserve venous function and further prevent development of post-thrombotic syndrome.

KW - Catheter-directed intrathrombus thrombolysis

KW - Deep vein thrombosis

KW - Low-molecular-weight heparin

KW - Post-thrombotic syndrome

KW - Unfractionated heparin

UR - http://www.scopus.com/inward/record.url?scp=84877793084&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84877793084&partnerID=8YFLogxK

U2 - 10.1016/j.jcma.2013.01.006

DO - 10.1016/j.jcma.2013.01.006

M3 - Article

C2 - 23683259

AN - SCOPUS:84877793084

VL - 76

SP - 265

EP - 270

JO - Journal of the Chinese Medical Association

JF - Journal of the Chinese Medical Association

SN - 1726-4901

IS - 5

ER -